Non-contrast Abbreviated MRI for Secondary Surveillance of HCC
NCT ID: NCT05690451
Last Updated: 2024-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
210 participants
OBSERVATIONAL
2021-12-28
2024-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance
NCT02854241
Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
NCT02551250
Abbreviated MRI for HCC Surveillance
NCT03731923
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
NCT06168357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-contrast abbreviated MRI
Liver MRI without contrast injection. The following sequences will be obtained from all of the participants.
* Axial heavily and regular T2 WI
* precontrast fat-suppressed T1 WI
* Diffusion-weighted image using b-value of 0, 50 or 400, and 800 or 1000
Contrast enhanced liver CT
Liver CT with iodine contrast injection This test will be served as a standard diagnostic test. The following phases will be obtained
* precontast, arterial phase, portal venous phase and delayed phase
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a history of curative treatment for HCC including surgical resection or local ablation
* No recurrence after curative treatment of HCC for more than two years
* Patient who has the plan to perform contrast-enhanced liver CT for secondary surveillance for HCC (i.e., to detect de novo or recurrent HCC)
Exclusion Criteria
* Previous history of severe allergic reaction to the iodinated contrast agent
* Patients with claustrophobia who can't undergo MR examination
* Patients having cochlear implants or cardiac pacemaker
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Ho Lee
Clinical professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dong Ho Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam, Korea (the Republic Of), South Korea
Asan Medical Center
Seoul, Korea (the Republic Of), South Korea
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KCT0006395
Identifier Type: REGISTRY
Identifier Source: secondary_id
H-2106-183-1230
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.